PTC Therapeutics’ AADC deficiency gene therapy granted FDA approval
PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...
PTC Therapeutics: Q3 Earnings Snapshot
The biopharmaceutical company posted revenue of $196.8 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $173.5 million. PTC Therapeutics expects full-year ...
digitalengineering2476d
Jon Peddie on Milestone Moments in the History of CAD
CAD industry blossomed and then shrunk due to acquisitions and mergers. Today we have about five or six major companies, but ...
PTC price target raised to $228 from $226 at Baird
Baird analyst Joe Vruwink raised the firm’s price target on PTC (PTC) to $228 from $226 and keeps an Outperform rating on the shares. The ...